Showing results (91-100 of 224) with videos related to

Sort By:
Pageof 23
Journal of Surgical Oncology|January 19, 2016
Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology GroupCarol D Morris, Lisa A Teot, Mark L Bernstein, et al.
Cancer|January 19, 2012
Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology GroupKatherine A Janeway, Donald A Barkauskas, Mark D Krailo, et al.
Archives of Pathology & Laboratory Medicine|March 26, 2021
Patterns of Translocation Testing in Patients Enrolling in a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing SarcomaSteven G DuBois, Mark D Krailo, Allen Buxton, et al.
Pediatric Blood & Cancer|September 16, 2023
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcomaKevin Campbell, Andrew Posner, Nan Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detectionSamuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Pediatric Blood & Cancer|July 2, 2024
Surgical management of liver tumorsKimberly J Riehle, Sanjeev A Vasudevan, Alexander Bondoc, et al.
The Journal of Molecular Diagnostics : JMD|July 29, 2021
Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA SequencingAlyaa Al-Ibraheemi, Juan Putra, Harrison K Tsai, et al.
Pediatric Blood & Cancer|September 8, 2021
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology GroupAnderson B Collier, Mark D Krailo, Ha M Dang, et al.
Pediatric Blood & Cancer|March 28, 2009
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinibKatherine A Janeway, Karen H Albritton, Annick D Van Den Abbeele, et al.
Pediatric Blood & Cancer|November 1, 2018
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology GroupMichael S Isakoff, Robert Goldsby, Doojduen Villaluna, et al.
Pageof 23